Inactief instrument

Koers Durata Therapeutics Inc

Aandelen

slotkoers Nasdaq Andere beurzen
- ^USD	-

Durata Therapeutics : Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults	01-06-15
Durata Therapeutics : Infectious Disease Experts, Scientists and Clinicians Join Forces on SHARE ID™ to Accelerate the Battle Against Antibiotic-resistant Infections	27-05-15
Durata Therapeutics : Actavis Confirms Generic Letairis® Patent Challenge	08-04-15
Durata Therapeutics : Actavis Announces Michael R. Gallagher and Peter J. McDonnell to Join Board of Directors	03-04-15
Durata Therapeutics : Actavis and Allergan Shareholders Approve Proposals Related to Actavis' Planned Acquisition of Allergan	12-03-15

Sector

	Vaira. 1 jan.	Kapi.
IQVIA HOLDINGS INC.	+1,51%	42,75 mld.
LONZA GROUP AG	+49,22%	41,61 mld.
MODERNA, INC.	+8,57%	41,34 mld.
CELLTRION, INC.	-12,36%	26,59 mld.
ICON PUBLIC LIMITED COMPANY	+8,92%	25,49 mld.
ALNYLAM PHARMACEUTICALS, INC.	-25,13%	18,12 mld.
MEDPACE HOLDINGS, INC.	+29,17%	12,24 mld.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3,12%	11,76 mld.
UNITED THERAPEUTICS CORPORATION	+6,35%	11 mld.